Nordhealth AS (OSL:NORDH)
Norway
· Delayed Price · Currency is NOK 27.00
-1.80 (-6.25%)
At close: Mar 9, 2026
Nordhealth AS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Operating Revenue | 45.65 | 40.2 | 33.09 | 28.22 | 18.46 | Upgrade
|
| Other Revenue | 5.19 | 5.48 | 3.74 | 2.83 | 1.84 | Upgrade
|
| Revenue | 50.84 | 45.68 | 36.83 | 31.05 | 20.3 | Upgrade
|
| Revenue Growth (YoY) | 11.31% | 24.03% | 18.60% | 52.96% | 60.04% | Upgrade
|
| Cost of Revenue | 37.3 | 30.01 | 27.66 | 27.04 | 13.64 | Upgrade
|
| Gross Profit | 13.54 | 15.67 | 9.16 | 4.01 | 6.67 | Upgrade
|
| Selling, General & Admin | - | 2.38 | 2.59 | 2.76 | 1.12 | Upgrade
|
| Amortization of Goodwill & Intangibles | 6.29 | 6.31 | 6.44 | 6.47 | 2.93 | Upgrade
|
| Other Operating Expenses | 14.73 | 10.2 | 7.82 | 7.23 | 5.77 | Upgrade
|
| Operating Expenses | 26.01 | 23.39 | 20.55 | 18.69 | 11.12 | Upgrade
|
| Operating Income | -12.47 | -7.73 | -11.39 | -14.68 | -4.46 | Upgrade
|
| Interest Expense | -0.04 | -0.04 | -0.01 | -0.02 | -0.04 | Upgrade
|
| Interest & Investment Income | - | 0.22 | 0.15 | 0.11 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.12 | -0.26 | 0.46 | -0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.22 | 0.78 | 0.7 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -12.29 | -6.64 | -10.81 | -14.13 | -4.65 | Upgrade
|
| Pretax Income | -12.29 | -6.64 | -10.81 | -14.13 | -4.65 | Upgrade
|
| Income Tax Expense | 0.39 | 1.04 | 0.33 | 0.14 | 0.09 | Upgrade
|
| Net Income | -12.68 | -7.67 | -11.13 | -14.26 | -4.73 | Upgrade
|
| Net Income to Common | -12.68 | -7.67 | -11.13 | -14.26 | -4.73 | Upgrade
|
| Shares Outstanding (Basic) | - | 79 | - | 80 | 80 | Upgrade
|
| Shares Outstanding (Diluted) | - | 79 | - | 80 | 80 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.24% | - | Upgrade
|
| EPS (Basic) | - | -0.10 | - | -0.18 | -0.06 | Upgrade
|
| EPS (Diluted) | - | -0.10 | - | -0.18 | -0.06 | Upgrade
|
| Free Cash Flow | -4.37 | -3.17 | -10.95 | -13.1 | 2.19 | Upgrade
|
| Free Cash Flow Per Share | - | -0.04 | - | -0.16 | 0.03 | Upgrade
|
| Gross Margin | 26.63% | 34.30% | 24.88% | 12.93% | 32.83% | Upgrade
|
| Operating Margin | -24.52% | -16.91% | -30.92% | -47.27% | -21.96% | Upgrade
|
| Profit Margin | -24.94% | -16.80% | -30.23% | -45.94% | -23.30% | Upgrade
|
| Free Cash Flow Margin | -8.60% | -6.94% | -29.72% | -42.20% | 10.79% | Upgrade
|
| EBITDA | -1.19 | -0.87 | -1.25 | -5.98 | -0.22 | Upgrade
|
| EBITDA Margin | -2.33% | -1.91% | -3.39% | -19.24% | -1.09% | Upgrade
|
| D&A For EBITDA | 11.28 | 6.86 | 10.14 | 8.7 | 4.24 | Upgrade
|
| EBIT | -12.47 | -7.73 | -11.39 | -14.68 | -4.46 | Upgrade
|
| EBIT Margin | -24.52% | -16.91% | -30.92% | -47.27% | -21.96% | Upgrade
|
| Revenue as Reported | 51.08 | 45.68 | 36.83 | 31.05 | 20.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.